四氢生物蝶呤对肝细胞癌血管生成的影响
该研究将HepG-2细胞皮下接种的BALB/c-nu小鼠随机分为对照组和BH4组,分别每日腹腔注射生理盐水或20 mg/kg BH4两周。BH4组肿瘤组织BH4、NO水平及肿瘤体积均显著高于对照组,CD34、K-ras、磷酸化eNOS、磷酸化Akt和GTPCH表达显著上调。结论认为BH4作为eNOS必需辅因子,可通过激活野生型Ras-PI3K/Akt通路增加肿瘤产生的NO,从而诱导血管生成。
要点
- BH4组肿瘤组织BH4水平为(0.24±0.02) μg/ml,显著高于对照组的(0.17±0.01) μg/ml(P<0.01)。
- BH4组肿瘤组织NO水平为(51.44±2.90) mmol/L,显著高于对照组的(24.77±0.54) mmol/L(P<0.01)。
- BH4组肿瘤体积为(191.05±8.70) mm3,显著高于对照组的(103.10±5.03) mm3(P<0.01)。
核心结论
- BH4作为eNOS的必需辅因子,可通过激活野生型Ras-PI3K/Akt通路增加肿瘤产生的NO,从而诱导血管生成。
- 靶向BH4合成通路并抑制血管生成可能为控制肝细胞癌进展提供新的有前景的途径。
研究设计与样本
- BALB/c-nu小鼠皮下注射HepG-2细胞后随机分为对照组和BH4组。
- BH4组和对照组分别每日腹腔注射20 mg/kg BH4或生理盐水,持续两周。
- 采用高效液相色谱法测定BH4水平,Griess试验阵列测定NO水平,定量RT-PCR测定K-ras转录水平,Western blot测定GTPCH、eNOS、磷酸化Akt和Akt蛋白表达。
主要发现
- BH4组肿瘤组织BH4水平为(0.24±0.02) μg/ml,显著高于对照组的(0.17±0.01) μg/ml(P<0.01)。
- BH4组肿瘤组织NO水平为(51.44±2.90) mmol/L,显著高于对照组的(24.77±0.54) mmol/L(P<0.01)。
- BH4组肿瘤体积为(191.05±8.70) mm3,显著高于对照组的(103.10±5.03) mm3(P<0.01)。
- 与对照组相比,BH4组肿瘤组织中CD34、K-ras、磷酸化eNOS、磷酸化Akt和GTPCH表达显著上调(P<0.01)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the effect and mechanism of tetrahydrobiopterin (BH4) on the angiogenesis in hepatocellular carcinoma (HCC). Methods: BALB/c-nu mice were subcutaneously injected with HepG-2 cells and randomly divided into control and BH4 groups. The BH4 group and control group received 20 mg/kg BH4 or saline by intraperitoneal injection daily for two weeks, respectively. The level of BH4 was measured by high performance liquid chromatography (HPLC), the level of nitric oxide (NO) was measured by Griess test array, the transcriptional level of K-ras was measured by quantitative RT-PCR, and the protein expressions of guanosine triphosphate cyclohydrolase Ⅰ(GTPCH), endothelial nitric oxide synthase (eNOS), phospho-Akt and Akt were determined by Western blot. Results: BH4 level in the tumor tissues of BH4 group was (0.24±0.02) μg/ml, significantly higher than the (0.17±0.01) μg/ml in the control group (P<0.01). The level of NO in the tumor tissues of BH4 group was (51.44±2.90) mmol/L, significantly higher than the (24.77±0.54) mmol/L in the control group (P<0.01). The tumor volume of BH4 group was (191.05±8.70) mm3, significantly higher than the (103.10±5.03) mm3 in the control group (P<0.01). The expressions of CD34, K-ras, phospho-eNOS, phospho-Akt and GTPCH were significantly up-regulated in the tumor tissues of BH4 group when compared with those of the control group (P<0.01). Conclusions: BH4 recognized as an essential cofactor of eNOS can increase tumor-produced NO by activating the wild-type Ras-PI3K/Akt pathway, thus induces angiogenesis. This might provide a novel and promising way to control the progression of hepatocellular carcinoma through targeting BH4 synthesis pathway and inhibiting angiogenesis.
引用
- Dai YG, Gan P, Li WM, et al. [Effects of tetrahydrobiopterin on the angiogenesis in hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi. 2016. PMID: 27998437. doi:10.3760/cma.j.issn.0253-3766.2016.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。